Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Immuno-intervention in cutaneous lymphomas].

R Dummer1, L Heinzerling, M H Schmid

  • 1Dermatologische Klinik, Universitätsspital Zürich. dummer@derm.unizh.ch

Praxis
|October 19, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[To Prof. Dr. Dr. h.c. mult. Otto Braun-Falco: Birthday wishes and expression of appreciation from the Swiss Society for Dermatology and Venereology (SGDV)].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2012
Same author

Skin diseases in Europe. Teledermatology.

European journal of dermatology : EJD·2009
Same author

Dermatopathology.

European journal of dermatology : EJD·2009
Same author

Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo.

Journal of the European Academy of Dermatology and Venereology : JEADV·2007
Same author

Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG.

Annals of oncology : official journal of the European Society for Medical Oncology·2006
Same author

[Telemedicine in dermatology 2003: a review].

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2005
Same journal

Praxis·2026
Same journal

[What do Swiss doctors think about cardiovascular risk factors and guidelines?]

Praxis·2026
Same journal

[Laser interstitial thermotherapy (LITT): a minimally invasive neurosurgical treatment option for brain tumours and radiation necrosis].

Praxis·2026
Same journal

[Persistent back pain after lifting trauma. From the trivial to the rare case].

Praxis·2026
Same journal

[A patient with dizziness and gait instability - a diagnostic challenge].

Praxis·2026
Same journal

[Meningoencephalitis caused by listeria monocytogenes].

Praxis·2026
See all related articles

Cutaneous lymphomas, a group of skin cancers, are often manageable with targeted immunotherapies. New treatments like anti-CD20 antibodies offer improved options for these rare cancers.

Area of Science:

  • Hematology
  • Immunology
  • Dermatology

Context:

  • Cutaneous lymphomas are diverse lymphoproliferative disorders affecting the skin.
  • Conventional treatments like radiotherapy and chemotherapy have limited efficacy.
  • Immunological interventions are a key therapeutic strategy for cutaneous lymphomas.

Purpose:

  • To review current and emerging immunological interventions for cutaneous lymphomas.
  • To highlight the potential of targeted therapies, such as anti-CD20 antibodies, for B-cell lymphomas.

Summary:

  • Discusses various immunotherapies including Interferon-alpha, Interleukin-2, photopheresis, fusion toxins, and antigen-loaded dendritic cells.
  • Introduces a new humanized anti-CD20 antibody for CD20-expressing cutaneous B-cell lymphomas.

Related Experiment Videos

  • Emphasizes the role of understanding immunobiology for developing more specific and tolerable treatments.

    • Impact:

    • Advances in understanding immunobiology are expected to drive more targeted and effective therapies.
    • Improved treatment tolerability for patients with cutaneous lymphomas.
    • Potential for better therapeutic outcomes through personalized immunological interventions.